Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Innate Pharma SA

www.innate-pharma.com

Latest From Innate Pharma SA

AstraZeneca Q3 Sales Rise 'Is Milestone', CEO Soriot 'Not Leaving'

AstraZeneca's third-quarter results show it has emerged from a long decline and returned to growth, fuelled by new products and pipeline, the UK pharma's CEO Pascal Soriot told reporters, adding that he's having too much fun turning the group around to leave any time soon.

Business Strategies Commercial

Asajes Offers Up Innovative Partnering Model For Asia Development

Asajes Ventures sees itself as offering a unique new mixed business model of venture capital and local development activity for smaller Western companies looking to develop their product or pipeline assets in Japan and China, aided by new opportunities from a rapidly reforming regulatory environment.

Business Strategies Market Access

Deal Watch: Alexion Encouraged By RNAi Developments, Partners With Dicerna

Alexion thinks Dicerna’s RNAi technology could address complement-mediated conditions further upstream from antibodies like Soliris. AbbVie takes over CF collaboration with Galapagos, paying $45m up front.

Deals Business Strategies

Innate Pharma's Expanded IO AstraZeneca Deal Jump-Starts US Ambitions

France's Innate Pharma gets a boost to its plans to become a fully integrated biotech by forging a long-term immuno-oncology development partnership with AstraZeneca, and the setting up of a commercialization team in the US.

 

ImmunoOncology Deals
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Inflammation
  • Alias(es)
  • Innate Pharma SAS
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Innate Pharma SA
  • Senior Management
  • Mondher Mahjoubi, MD, CEO
    Laure-Helene Mercier, EVP, CFO
    Yannis Morel, PhD, EVP, Bus. Dev.
    Pierre Dodion, MD, EVP, CMO
    Eric Vivier, DVM, PhD, SVP, CSO
  • Contact Info
  • Innate Pharma SA
    Phone: (33) 4 30 30 30 30
    117, Ave. de Luminy
    BP 30191
    Marseille Cedex 09 , 13276
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register